Regeneron promotes Christopher Fenimore to CFO, announces board changes

While the company added Kathryn Guarini, PhD and David P. Schenkein, MD to its board, Regeneron announced the departure of Marc Tessier-Lavigne, PhD effective September 1.

Related Keywords

Christopher Fenimore ,Roberte Landry ,Leonards Schleifer ,Marc Tessier Lavigne ,Christine Poon ,Kathryn Guarini ,Davidp Schenkein ,Stanford University ,Millennium Pharmaceuticals ,Ibm ,Agios Pharmaceuticals ,Genentech ,Mojave Therapeutics ,Google Ventures ,